Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Question and Answer Webinar Special Notice
Archived on February 25, 2026. Special Notice posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF (NATIONAL INSTITUTES OF HEALTH) on February 6, 2026. Solicitation ARPA-H-SN-26-148.
NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Set-aside: No Set aside used. Place of performance: Washington, District of Columbia. Original response deadline: . Full description on SAM.gov.
Description
This Special Notice (SN) is intended to alert the scientific community to an Advanced Research Projects Agency for Health (ARPA-H) Program and notify potential proposers of the ADVOCATE Question and Answer (Q&A) Webinar. The Scalable Solutions Office (SSO) is sponsoring a non-mandatory Q&A Webinar for the planned proposer community in support of the ADVOCATE program. This session is intended to provide additional clarification on the ADVOCATE Innovation Solutions Opening (ISO), ARPA-H-SOL-26 142, and to address questions that may have arisen following the Proposers’ Day held on January 23, 2026.
See attached SN ARPA-H-SN-26-148 for further details.
Overview
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Documents
Showing 1 of 1 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Special Notice | NATIONAL INSTITUTES OF HEALTH | Feb 6, 2026 | 258.18 KB |
Lifecycle
ARPA-H-SN-26-148- Special NoticeCurrentFeb 6, 2026
Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Question and Answer Webinar Special Notice
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Amendment 01: The Proposers' Day has been updated to October 16th, 2026. The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached UNIQUE-ISO-ARPA-H-SOL-26-162 and UNIQUE ISO Attachments. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-162, for information regarding the UNIQUE Proposers’ Day. Special Notice, ARPA-H-SN-26-162, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the UNIQUE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/unique/faqs | Solicitation | 541714 | No Set-Aside | 09/24/2026 | 12/15/2026 | - | |
The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached UNIQUE-ISO-ARPA-H-SOL-26-162 and UNIQUE ISO Attachments. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-162, for information regarding the UNIQUE Proposers’ Day. Special Notice, ARPA-H-SN-26-162, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the UNIQUE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/unique/faqs | Solicitation | 541714 | No Set-Aside | 09/16/2026 | 12/16/2026 | - | |
The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached UNIQUE-ISO-ARPA-H-SOL-26-162 and UNIQUE ISO Attachments. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-162, for information regarding the UNIQUE Proposers’ Day. Special Notice, ARPA-H-SN-26-162, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the UNIQUE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/unique/faqs | Solicitation | 541714 | No Set-Aside | 09/16/2026 | 12/15/2026 | - | |
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) aims to or seeks to ensure ARPA-H identifies and engages early career investigators. To achieve this goal, ARPA-H is soliciting proposals from these researchers and innovators and their organizations to develop cutting-edge biomedical, health, and community-engaged research and innovation. ARPA-H anticipates multiple Other Transaction awards resulting from this announcement Amendment 1: This amendment clarifies the number of submissions that may be submitted by each offeror. See section 2.4 of the ISO. It also updates the solution summary cover sheet and the FAQ. | Solicitation | 541714 | No Set-Aside | 09/25/2026 | 02/10/2027 | - | |
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) aims to or seeks to ensure ARPA-H identifies and engages early career investigators. To achieve this goal, ARPA-H is soliciting proposals from these researchers and innovators and their organizations to develop cutting-edge biomedical, health, and community-engaged research and innovation. ARPA-H anticipates multiple Other Transaction awards resulting from this announcement | Solicitation | 541714 | No Set-Aside | 09/15/2026 | 02/10/2027 | - |
Additional Details
Solicitation Number
ARPA-H-SN-26-148
Archive Date
Feb 25, 2026
Office Address
Washington, DC, 20005